Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats

Neuroscience Letters

Volumn 265, Issue 1, 1999, Pages 33-36

  Koyama, Takako ^a   Nakajima, Yasuo ^a   Fujii, Takeshi ^a   Kawashima, Koichiro ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; BAY x 3702; Cerebral cortex; Hippocampus; Microdialysis; Serotonin1A (5 HT1A) receptor; WAY 100635

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; DESIPRAMINE; LITHIUM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; REPINOTAN; SEROTONIN 1A RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; BRAIN CORTEX; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; BENZOPYRANS; CEREBRAL CORTEX; HIPPOCAMPUS; MALE; MOVEMENT; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SYNAPTIC TRANSMISSION; THIAZOLES;

EID: 0033538023     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00200-1     Document Type: Article

References (21)

1. Bianchi C., Siniscalchi A., Beani L. 5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br. J. Pharmacol. 101:1990;448-452.
2. Consolo S., Ramponi S., Ladinsky H., Baldi G. A critical role for D1 receptors in the 5-HT1A -mediated facilitation of in vivo acetylcholine release in rat frontal cortex. Brain Res. 707:1996;320-323.
3. Detke M.J., Wieland S., Lucki I. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5-HT1A receptor antagonists, Psychopharmacology (Berl. 119:1995;47-54.
4. De Vry J., Dietrich H., Schohe-Loop R., Heine H.G., Greuel J.M., Mauler F., Schmidt B., Sommermeyer H., Glaser T. Characterization of the aminomethylchroman derivative BAY×3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. J. Pharmacol. Exp. Ther. 284:1998;1082-1094.
5. De Vry J., Glaser T., Heine H.G., Horvath E., Jork R., Maertins T., Mauler F., Opitz W., Scherling D., Schohe-Loop R., Schwarz T. BAY(3702. Drugs Fut. 22:1997;341-349.
6. Forster E.A., Cliffe L.A., Bill D.J., Dover G.M., Jones D., Reilly Y., Fletcher A. A pharmacological profile of the selective silent 5-HT1A receptor antagonist WAY-100635. Eur. J. Pharmacol. 281:1995;81-88.
7. Fujii T., Yoshizawa M., Nakai K., Fujimoto K., Suzuki T., Kawashima K. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. Brain Res. 761:1997;244-249.
8. Gillet G., Ammor S., Fillon G. Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect. J. Neurochem. 45:1985;1687-1691.
9. Goodwin G.M., De Souza R.J., Wood A.J., Green A.R. The enhancement by lithium of the 5-HT1A -mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism. Psychopharmacology. 90:1986;488-493.
10. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol. Rev. 46:1994;157-203.
11. Izumi J., Washizuka M., Miura N., Hiraga Y., Ikeda Y. Hippocampal serotonin 5-HT1A receptor enhances acetylcholine release in conscious rats, J. Neurochem. 62:1994;1804-1808.
12. Kawashima K., Ishikawa H., Mochizuki M. Radioimmunoassay for acetylcholine in the rat brain, J. Pharmacol. Methods. 3:1980;115-123.
13. Kawashima K., Hayakawa T., Kashima Y., Suzuki T., Fujimoto K., Oohata H. Determination of acetylcholine release in the striatum of anesthetized rats using in vivo microdialysis and a radioimmunoassay. J. Neurochem. 57:1991;882-887.
14. Kawashima K., Sato A., Yoshizawa M., Fujii T., Fujimoto K., Suzuki T. Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;523-528.
15. Maura G., Fedele E., Raiteri M. Acetylcholine release from rat hippocampus slices is modulated by 5-hydroxytryptamine. Eur. J. Pharmacol. 165:1989;173-179.
16. Nakai K., Fujii T., Fujimoto K., Suzuki T., Kawashima K. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis, Neurosci. Res. 31:1998;23-29.
17. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, Sydney.
18. Siniscalchi A., Beani L., Bianchi C. Different effects of 8-OH-DPAT, a 5-HT1A receptor agonist, on cortical acetylcholine release, electrocortigram and body temperature in guinea pigs and rats, Eur. J. Pharmacol. 175:1990;219-223.
19. Tricklebank M.D., Forler C., Fozard J.R. The involvement of subtypes of 5-HT1 receptor and catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur. J. Pharmacol. 106:1984;271-282.
20. Verge D., Daval G., Marcinkiewicz M., Patey A. El Mestikawy. S., Gozlan, H. and Hamon, M., Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats, J. Neurosci. 6:1986;3474-3482.
21. Wilkinson L.O., Middlemiss D.N., Hutson P.H. 5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo. J. Pharmacol. Exp. Ther. 270:1994;656-664.